Pharmaceutical foreign trade balanced development

Custom Synthesis, Data show that the first three quarters of this year, China’s pharmaceutical foreign trade total of 84.953 billion U.S. dollars, year-on-year growth of 10.71%. Among them, exports of 43.678 billion U.S. dollars, year-on-year growth of 5.61%, imports of 41.275 billion U.S. dollars, year-on-year growth of 16.66%. The surplus was $2.403 billion, down 59.8% per cent from a year earlier. Broken down into three categories of goods, Chinese medicine exports 2.6 billion U.S. dollars, slightly lower than 0.27%, western medicine exports 25.395 billion U.S. dollars, year-on-year growth of 8.44%, medical equipment exports 15.684 billion U.S. dollars, year-on-year growth of 2.29%.

China Medical and Health products import and export Chamber of Commerce Vice President Meng Dongping in the Canton Fair at the scene of the “medical Economic newspaper” reporter interviewed, pointed out that China’s long-term reliance on low-cost raw materials products have quietly changed the situation, began to turn to high value-added, embodies high-tech capabilities of products. She said that expanding the import of pharmaceutical products is an objective need to promote China’s economic development and an effective means to achieve a balanced development of pharmaceutical foreign trade. In January-September, China’s imports of pharmaceutical products were $41.275 billion, almost balanced with exports, with imports increasing more than 11.05%. Among them, the traditional Chinese medicine and medical devices, such as the increase in prices fell, Western medicine, such as the price of double liters. At present, our country imported products to high-end medical equipment, pharmaceutical equipment and Western medicine, and domestic industry complementary strong, collocation reasonable, can effectively improve domestic related supply, conducive to industrial restructuring and optimization and upgrading.